Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori

Helicobacter

Volumn 9, Issue 5, 2004, Pages 396-399

  Toracchio, Sonia ^a   Aceto, Gitana M ^a   Mariani Costantini, Renato ^a   Battista, Pasquale ^a   Marzio, Leonardo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

23S rRNA gene; Clarithromycin resistance; H. pylori; Italy; Mutations

Indexed keywords

23S RRNA; CLARITHROMYCIN; PEPTIDYLTRANSFERASE; RIBOSOME RNA; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; DYSPEPSIA; ERADICATION THERAPY; GENE MUTATION; GENE SEQUENCE; HELICOBACTER PYLORI; ITALY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ITALY; MUTATION; NUCLEIC ACID CONFORMATION; PEPTIDYL TRANSFERASES; PREVALENCE; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; URBAN POPULATION; VARIATION (GENETICS);

HELICOBACTER; HELICOBACTER PYLORI;

EID: 4644310433     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1083-4389.2004.00267.x     Document Type: Article

References (22)

1. Logan RP, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994;35: 323-6.
2. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Siponi P. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
3. Goldman RC, Zakula D, Flamm R, Beyer I, Capobianco I. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 1994;38:1496-500.
4. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40: 477-80.
5. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of the two copies of 23S rRNA genes from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997;41:2621-8.
6. Occhialini A, Urdaci M, Doucet-Populaire F, Bebear CM, Lamouliatte H, Mégraud F. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997;41:2724-8.
7. Stone GG, Shortridge D, Flamm RK, et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996;1:227-8.
8. Hultén K, Gibreel A, Skold O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997;41:2550-3.
9. Kim KS, Kang JO, Eun CS, Han DS, Choi TY. Mutation in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance. J Korean Med Sci 2002;17:599-603.
10. Piana A, Are BM, Maida I, et al. Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains. New Microbiol 2002;25:123-30.
11. Pilotto A, Rassu M, Leandro G, Franceschi M, Di Mario F. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicenter study. Dig Liver Dis 2000;32:763-8.
12. Fontana C, Favaro M, Minelli S, et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002;46:3765-9.
13. Toracchio S, Marzio L. Primary and secondary resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Digest Liver Dis 2003;35:541-5.
14. Mégraud F, Bonnet F, Garnier M, Lamouliatte H. Characterization of Campylobacter pyloridis by culture, enzymatic profile, and protein content. J Clin Microbiol 1985;22:1007-10.
15. National Committee for Clinical Laboratory Standards. Approved standard M100-S10. MIC testing supplemental tables. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2000.
16. Glupczynski Y, Labbè M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991;29: 2072-5.
17. Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Aliment Pharmacol Ther 2001;15:707-13.
18. Heep M, Kist M, Strobel S, Beck D, Lehn N. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 2000;19:538-41.
19. Vester B, Douhwaite S. Macrolide resistance by base substitutions in the 23S rRNA. Antimicrob Agents Chemother 2001;45:1-12.
20. Kim JJ, Kim JG, Kwon DH. Mixed infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003;8:202-6.
21. Wang GE, Jiang Q, Taylor DE. Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrealed isolates. J Clin Microbiol 1998;36:2730-1.
22. van der Ende A, van Doom LJ, Rooijakkers S, Feller M, Tytgat GNJ, Danken J. Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J Clin Microbiol 2001;39:2648-51.